| Devatis AG - Temozolomid Devatis 250 mg, Kapseln | | 68606 | | 06 | | Temozolomid Devatis 250 mg | | Kapseln | | L01AX03 | | Temozolomid | | 17.11.2022 | | |
| | Composition | | temozolomidum 250 mg, lactosum 154.3 mg, carboxymethylamylum natricum A corresp. natrium max. 0.9 mg, silica colloidalis anhydrica, acidum tartaricum, acidum stearicum, Kapselhülle: gelatina, E 171, Drucktinte: lacca, E 172 (nigrum), propylenglycolum, ammonii hydroxidum, pro capsula. | | Packungsbestandteile | | Capsules | | | | | Principe actif | Concentr. |
|---|
| Temozolomide | 250 mg |
| | BAG: Principe actif | Concentr. |
|---|
| Temozolomide | 250 mg |
| | | | Agents auxilliaires | Concentr. | informations additionels |
|---|
| (Nigrum) | | | | Acidum Stearicum | | | | Acide Tartarique | | | | Ammonii Hydroxidum | | | | Carboxymethylamylum Natricum A | | | | E 171 | | color. | | E 172 | | color. | | Gelatina | | Kapselhülle | | Lacca | | Drucktinte | | Lactosum | 154.3 mg | | | Pro Capsula | | | | Propylenglycol | | | | Silica Colloidalis Anhydrica | | |
| |
| |
|
